Related Experiment Video
Updated: Jul 14, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
[Sleep deprivation as antidepressive treatment].
Håvard Kallestad1, Knut Langsrud, Bjarne Hansen
1St. Olavs Hospital Psykiatrisk divisjon, avdeling Østmarka, 7006 Trondheim. havard.kallestad@ntnu.no
Sleep deprivation is a fast-acting antidepressant treatment. While its effects are temporary, combining it with other therapies can prolong benefits and improve depression outcomes.
Area of Science:
- Psychiatry
- Sleep Medicine
- Neuroscience
Context:
- Sleep deprivation, a treatment involving approximately 35 hours of wakefulness, is an underutilized antidepressant therapy in Norway.
- Existing literature confirms sleep deprivation as a documented treatment for depression, though its clinical application is limited.
Purpose:
- To review the efficacy and potential of sleep deprivation as an antidepressant treatment.
- To illustrate the application of sleep deprivation therapy with clinical case examples.
- To explore methods for prolonging the transient antidepressant effects of sleep deprivation.
Summary:
- Sleep deprivation offers rapid symptom reduction for depression, comparable to standard treatments but with a quicker onset.
- Transient antidepressant effects can be extended through sleep phase advancement, pharmacotherapy, and light therapy.
- Two pilot patients achieved over 50% symptom reduction within three days of sleep deprivation therapy.
Impact:
- Highlights the potential of sleep deprivation for rapid depression relief.
- Suggests further research into prolonged treatment courses and mechanisms of action.
- Indicates a need to investigate sleep quality and diurnal rhythm stabilization as outcomes of sleep deprivation therapy.
More Related Videos
06:45Effect of Yi-Nao-Jie-Yu Prescription on Post-Stroke Depression in Rats using Middle Cerebral Artery Occlusion Combined with Behavioral Restraint
Published on: January 9, 2026
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Management of Insomnia
Antidepressant Drugs: Overview
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Anxiolytic Drugs: Overview
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.